CAMBRIDGE, Mass. — Aug 4, 2026 — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology. The peer-reviewed paper demonstrates how advanced artificial intelligence combined with comprehensive multi-omic analysis can successfully identify promising therapeutic targets in one of the rarest and least understood forms of head and neck cancer.

A new study led by Swansea University has laid bare the devastating impact that soaring infant formula milk prices are having on the health, finances, and mental wellbeing of UK parents and their children.

AMHERST, Mass. — Radiopharmaceutical therapy (RPT) has made great strides over the last 50 years, having only recently received FDA approval to treat prostate cancer. But despite the progress—and billions of dollars of industry investments—one area that has lagged behind is dosing, which is still one-size-fits-all. Now, researchers at the University of Massachusetts Amherst have developed an AI model that can inform treatment individualization by generating a patient’s radiation dose map that matches gold-standard accuracy in under 23 seconds.

One in six UK hospital beds is currently occupied by a person with dementia, at a cost to the taxpayer of £2.8 billion annually, with this number set to increase to one in four by 2040, according to a new report by University College London (UCL) researchers.

These findings overturned the long-held dogma that the brain was entirely isolated from immune activity, and that any immune activity within the brain was inherently detrimental and should therefore be suppressed.

In a mouse model, LMU researchers have discovered a signaling pathway through which diet influences the development of the immune system.